FindTrial
Sign In

A survival prediction model for multiple myeloma in Chinese patients

A survival prediction model for multiple myeloma in Chinese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070436
Enrollment
Unknown
Registered
2023-04-12
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma

Interventions

Case series:None

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All enrolled patients were diagnosed with MM according to the multiple myeloma criteria of the International Myeloma Working Group and had not received previous antimyeloma therapy.

Exclusion criteria

Exclusion criteria: 1. Subjects with incomplete data before initial treatment were not included in this study. 2. Subjects are unwilling to accept collection of personal clinically relevant information.

Design outcomes

Primary

MeasureTime frame
progression-free survival, PFS;overall survival, OS;—

Countries

China

Contacts

Public ContactGeng Chuanying

Beijing Chaoyang Hospital, Capital Medical University

gengcy2000@126.com+86 13691476454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026